15-44490806-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_016396.3(CTDSPL2):āc.498A>Gā(p.Pro166Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00306 in 1,612,968 control chromosomes in the GnomAD database, including 144 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.016 ( 80 hom., cov: 32)
Exomes š: 0.0017 ( 64 hom. )
Consequence
CTDSPL2
NM_016396.3 synonymous
NM_016396.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.13
Genes affected
CTDSPL2 (HGNC:26936): (CTD small phosphatase like 2) Enables RNA polymerase II CTD heptapeptide repeat phosphatase activity. Predicted to act upstream of or within negative regulation of BMP signaling pathway; positive regulation of protein export from nucleus; and protein dephosphorylation. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 15-44490806-A-G is Benign according to our data. Variant chr15-44490806-A-G is described in ClinVar as [Benign]. Clinvar id is 784321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0549 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTDSPL2 | NM_016396.3 | c.498A>G | p.Pro166Pro | synonymous_variant | 5/13 | ENST00000260327.9 | NP_057480.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTDSPL2 | ENST00000260327.9 | c.498A>G | p.Pro166Pro | synonymous_variant | 5/13 | 1 | NM_016396.3 | ENSP00000260327.4 | ||
CTDSPL2 | ENST00000558966.5 | c.498A>G | p.Pro166Pro | synonymous_variant | 5/13 | 1 | ENSP00000452837.1 | |||
CTDSPL2 | ENST00000558373.5 | c.475+4106A>G | intron_variant | 1 | ENSP00000453051.1 | |||||
CTDSPL2 | ENST00000558791.5 | c.*2A>G | downstream_gene_variant | 4 | ENSP00000453612.1 |
Frequencies
GnomAD3 genomes AF: 0.0165 AC: 2511AN: 152194Hom.: 79 Cov.: 32
GnomAD3 genomes
AF:
AC:
2511
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00412 AC: 1036AN: 251244Hom.: 29 AF XY: 0.00309 AC XY: 420AN XY: 135782
GnomAD3 exomes
AF:
AC:
1036
AN:
251244
Hom.:
AF XY:
AC XY:
420
AN XY:
135782
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00166 AC: 2427AN: 1460656Hom.: 64 Cov.: 31 AF XY: 0.00146 AC XY: 1061AN XY: 726674
GnomAD4 exome
AF:
AC:
2427
AN:
1460656
Hom.:
Cov.:
31
AF XY:
AC XY:
1061
AN XY:
726674
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0165 AC: 2513AN: 152312Hom.: 80 Cov.: 32 AF XY: 0.0158 AC XY: 1179AN XY: 74482
GnomAD4 genome
AF:
AC:
2513
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
1179
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at